OBJECTIVE: The authors put forward the hypotheses that during a three-month treatment with tianeptine in patients with depressive disorders there is an improvement in the short-term memory, reaction time and attention. SUBJECT AND METHODS: 20 patients suffering from depression, were included in the study. During the entire research period all patients were treated with monotherapy with tianeptine. Cognitive function measurements were performed using the Vienna Test System. RESULTS: Our study showed an improvement in the all the assessed functions: patients treated with tianeptine had better performance in tests measuring short term memory and learning processes as well as reaction time and attention. CONCLUSION: In conclusion, the study shows that tianeptine improves cognitive functions in depressed patients.
OBJECTIVE: The authors put forward the hypotheses that during a three-month treatment with tianeptine in patients with depressive disorders there is an improvement in the short-term memory, reaction time and attention. SUBJECT AND METHODS: 20 patients suffering from depression, were included in the study. During the entire research period all patients were treated with monotherapy with tianeptine. Cognitive function measurements were performed using the Vienna Test System. RESULTS: Our study showed an improvement in the all the assessed functions: patients treated with tianeptine had better performance in tests measuring short term memory and learning processes as well as reaction time and attention. CONCLUSION: In conclusion, the study shows that tianeptine improves cognitive functions in depressedpatients.
Authors: Małgorzata Szafarz; Agnieszka Wencel; Krzysztof Pociecha; Filip A Fedak; Piotr Wlaź; Elżbieta Wyska Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2017-12-12 Impact factor: 3.000
Authors: Robert H Wichers; James L Findon; Auke Jelsma; Vincent Giampietro; Vladimira Stoencheva; Dene M Robertson; Clodagh M Murphy; Sarah Blainey; Grainne McAlonan; Christine Ecker; Katya Rubia; Declan G M Murphy; Eileen M Daly Journal: Mol Autism Date: 2021-02-19 Impact factor: 7.509
Authors: Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho Journal: BMC Med Date: 2016-01-22 Impact factor: 8.775